Skip to main content
TipRanks
Go Ultimate75% OFF

Cooper Co (COO) Revenue by Segment

672 Followers

Revenue by Segment

Cooper Co reported revenue by segment of $1.07B in Q3 FY2026, down 1.4% from Q2 FY2026 and up 0.6% year over year. The highest value was $1.08B in Q2 FY2026.

Shows how different parts of the business contribute to overall sales, highlighting strengths and potential areas for growth within the company's diverse operations.

$0.00$250.00M$500.00M$750.00M$1.00BJan 21Apr 21Jul 21Oct 21Jan 22Apr 22Jul 22Oct 22Jan 23Apr 23Jul 23Oct 23Jan 24Apr 24Jul 24Oct 24Jan 25Apr 25Jul 25Oct 25Jan 26Apr 26Jul 26
Chart Insights

CooperVision is the steady-growth engine—consistent organic lens demand and new product momentum (MiSight, daily silicone hydrogel) underpin resilience even as Asia softness and near-term margin pressure from FX, tariffs and inventory optimization bite. CooperSurgical is the faster-growth lever—fertility, genomics and capital equipment have materially lifted contribution since 2022, and management’s strategic review (broad external interest) could unlock value or introduce execution risk. Monitor how litigation payouts and any transaction proceeds affect buybacks, FCF allocation and near-term margin recovery.

COO Revenue by Segment

PeriodCooperVisionCooperSurgicalTotal
Q3 FY2026Jul 31, 2026$717.00M$349.20M$1.07B
Q2 FY2026Apr 30, 2026$723.50M$358.00M$1.08B
Q1 FY2026Jan 31, 2026$695.10M$329.00M$1.02B
Q4 FY2025Oct 31, 2025$709.60M$355.60M$1.07B
Q3 FY2025Jul 31, 2025$718.40M$341.90M$1.06B
Q2 FY2025Apr 30, 2025$669.60M$332.70M$1.00B
Q1 FY2025Jan 31, 2025$646.10M$318.60M$964.70M
Q4 FY2024Oct 31, 2024$676.40M$342.00M$1.02B
Q3 FY2024Jul 31, 2024$675.60M$327.20M$1.00B
Q2 FY2024Apr 30, 2024$635.90M$306.70M$942.60M
Q1 FY2024Jan 31, 2024$621.50M$310.10M$931.60M
Q4 FY2023Oct 31, 2023$622.90M$304.20M$927.10M
Q3 FY2023Jul 31, 2023$630.20M$300.00M$930.20M
Q2 FY2023Apr 30, 2023$589.30M$288.10M$877.40M
Q1 FY2023Jan 31, 2023$581.30M$277.20M$858.50M
Q4 FY2022Oct 31, 2022$561.70M$286.30M$848.00M
Q3 FY2022Jul 31, 2022$566.30M$277.10M$843.40M
Q2 FY2022Apr 30, 2022$553.80M$276.00M$829.80M
Q1 FY2022Jan 31, 2022$561.50M$225.70M$787.20M
Q4 FY2021Oct 31, 2021$564.90M$194.20M$759.10M
Q3 FY2021Jul 31, 2021$557.50M$205.90M$763.40M
Q2 FY2021Apr 30, 2021$522.60M$196.90M$719.50M
Q1 FY2021Jan 31, 2021$507.00M$173.50M$680.50M
Q4 FY2020Oct 31, 2020$506.30M$175.30M$681.60M
Q3 FY2020Jul 31, 2020$449.30M$128.90M$578.20M
Q2 FY2020Apr 30, 2020$402.20M$122.70M$524.90M
Q1 FY2020Jan 31, 2020$485.20M$161.00M$646.20M

Related KPIs